← Eichor
Study identifier: NCT06257394 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Treatment of Pediatric Very High-risk Acute Lymphoblastic Leukemia in Korea

Condition: Acute Lymphoblastic Leukemia, Pediatric  ·  Sponsor: Hyoung Jin Kang

PhasePhase 2
Planned participants74
Who can joinAll sexes, 1 Year to 19 Years
Healthy volunteersNo

About this study

Very high-risk acute lymphoblastic leukemia

This description comes directly from the study's public registry record.

Talk to the study team

Hyoung Jin Kang, Ph.D  ·  +82-2-2072-3452  ·  kanghj@snu.ac.kr

Hyoung Jin Kang  ·  +82220723452  ·  kanghj@snu.ac.kr

Always discuss trial participation with your own doctor first.

Locations (6)

Seoul National University HospitalSeoul, South KoreaRecruiting
Severance HospitalSeoul, South KoreaRecruiting
Asan Medical CenterSeoul, South KoreaRecruiting
Samsung Medical CenterSeoul, South KoreaRecruiting
Seoul saint Mary's HospitalSeoul, South KoreaRecruiting
Pusan National University Yangsan HospitalYangsan, South KoreaNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06257394